Tubeless Insulin Pump Market Outlook 2025–2034

Tubeless Insulin Pump Market - By Technology, By Distribution Channel, By End Use - Global Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/Country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp; Industry 360&deg; synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Technology trends

2.2.3&nbsp;&nbsp;&nbsp; Distribution channel trends

2.2.4&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights 

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising prevalence of diabetes

3.2.1.2&nbsp;&nbsp;&nbsp; Technological advancements in tubeless insulin pumps

3.2.1.3&nbsp;&nbsp;&nbsp; Increasing diabetes care expenditure

3.2.1.4&nbsp;&nbsp;&nbsp; Injuries caused by conventional &amp; invasive insulin pumps

3.2.1.5&nbsp;&nbsp;&nbsp; Adoption of facilitative initiatives

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High long-term costs associated with the tubeless insulin pumps

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent government regulations

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Shift toward wearable &amp; user-friendly devices

3.2.3.2&nbsp;&nbsp;&nbsp; Growing adoption in homecare

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; North America

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.5.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.6&nbsp;&nbsp;&nbsp; Technology and innovation landscape

3.6.1&nbsp;&nbsp;&nbsp; Current technological trends

3.6.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.7&nbsp;&nbsp;&nbsp; Future market trends

3.8&nbsp;&nbsp;&nbsp; Incidence &amp; prevalence of diabetes, by region, 2021-2024

3.8.1&nbsp;&nbsp;&nbsp; North America

3.8.2&nbsp;&nbsp;&nbsp; Europe

3.8.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.8.4&nbsp;&nbsp;&nbsp; RoW

3.9&nbsp;&nbsp;&nbsp; New product development landscape

3.10&nbsp;&nbsp;&nbsp; Start-up scenario

3.11&nbsp;&nbsp;&nbsp; Pricing analysis, 2024

3.12&nbsp;&nbsp;&nbsp; Investment landscape

3.13&nbsp;&nbsp;&nbsp; Consumer behaviour analysis

3.14&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.15&nbsp;&nbsp;&nbsp; PESTEL analysis

3.16&nbsp;&nbsp;&nbsp; Gap analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.2.1&nbsp;&nbsp;&nbsp; Global

4.2.2&nbsp;&nbsp;&nbsp; North America

4.2.3&nbsp;&nbsp;&nbsp; Europe

4.2.4&nbsp;&nbsp;&nbsp; Asia Pacific

4.2.5&nbsp;&nbsp;&nbsp; RoW

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Mergers &amp; acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships &amp; collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Continuous glucose monitoring (CGM) integrated pumps

5.3&nbsp;&nbsp;&nbsp; Standard tubeless pumps

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Brick and mortar

6.3&nbsp;&nbsp;&nbsp; E-commerce

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Homecare

7.3&nbsp;&nbsp;&nbsp; Hospitals &amp; clinics

7.4&nbsp;&nbsp;&nbsp; Other end use

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.5&nbsp;&nbsp;&nbsp; RoW

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles 

9.1&nbsp;&nbsp;&nbsp; Insulet

9.2&nbsp;&nbsp;&nbsp; MannKind Corporation

9.3&nbsp;&nbsp;&nbsp; Medtrum

9.4&nbsp;&nbsp;&nbsp; MicroTech

9.5&nbsp;&nbsp;&nbsp; Pharmasens

9.6&nbsp;&nbsp;&nbsp; Roche

9.7&nbsp;&nbsp;&nbsp; TERUMO

&nbsp;&nbsp;&nbsp;

Tubeless Insulin Pump Market

Inquiry Before Buying